However, with the increasing prevalence of CKD-inducing pathologies such as diabetes mellitus or hypertension in today’s society49,50 that may persistently trigger FGF23 production, the cost of some FGF23-related functions has exceeded their benefit, thus culminating in disease. This evidence concerns the gene FGF23 and chronic kidney disease.